Skip to main content
. Author manuscript; available in PMC: 2020 Mar 11.
Published in final edited form as: J Mol Cell Cardiol. 2019 Apr 18;131:53–65. doi: 10.1016/j.yjmcc.2019.04.016

Fig. 6.

Fig. 6.

Quantification of selected cytokines in CM-NSF and CM-SF in WT (A), HHD (B) and HFpEF (C) at 21 weeks. Myocardial tissue levels of ET-1 in the left atrium (D). Diastolic (E) and systolic Ca (F) after 1 h incubation with CM-SF in the presence of ET-1 receptor antagonist Bosentan or IP3 receptor inhibitor 2-APB. Reference for CM-SF (with or without Bosentan/2-APB) was obtained in two different sets of experiments with n = 13 and n = 11 CM-NSF cells. Dashed lines indicate respective Ca levels after treatment with NT2, CM-NSF and CM-SF without Bosentan/2-APB. *p < .05.